{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T19:46:57Z","timestamp":1789328817658,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"science and Technology Project of Tianjin Municipal Health Commission","award":["2023BWKY008"],"award-info":[{"award-number":["2023BWKY008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-024-03396-2","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T10:02:15Z","timestamp":1728900135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic significance of malignant pleural effusions in patients with advanced luminal B breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"You-ming","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yan-Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Wen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"3396_CR1","doi-asserted-by":"crossref","unstructured":"Hassan M, M R, Mercer NA, Maskell R, Asciak DJ, McCracken E, et al. Survival in patients with malignant pleural effusion undergoing talc pleurodesis. Lung Cancer. 2019;137:14\u20138.","DOI":"10.1016\/j.lungcan.2019.09.003"},{"issue":"7","key":"3396_CR2","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.21037\/gs-22-142","volume":"11","author":"W Li","year":"2022","unstructured":"Li W, Zheng Y, Wu H, Li X. Breast-conserving therapy versus mastectomy for breast cancer: a ten-year follow-up single-center real-world study. Gland Surg. 2022;11(7):1148\u201365.","journal-title":"Gland Surg"},{"issue":"10","key":"3396_CR3","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.amjmed.2022.04.017","volume":"135","author":"Shameek Gayen","year":"2022","unstructured":"Shameek Gayen. Malignant pleural effusion: presentation, diagnosis, and management. Am J Med. 2022;135(10):1188\u201392.","journal-title":"Am J Med"},{"key":"3396_CR4","first-page":"e41689","volume":"15","author":"AM Peel","year":"2023","unstructured":"Peel AM, Mishra EK. The Psychosocial Impact of Indwelling Pleural catheters: a scoping review. Cureus. 2023;15:e41689.","journal-title":"Cureus"},{"key":"3396_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.chest.2021.03.059","volume":"160","author":"S Molina","year":"2021","unstructured":"Molina S, Martinez-Zayas G, Sainz PV, et al. Breast and lung effusion survival score models: improving survival prediction in patients with malignant pleural effusion and metastasis. Chest. 2021;160:1075\u201394.","journal-title":"Chest"},{"key":"3396_CR6","doi-asserted-by":"crossref","unstructured":"Mark E, Roberts NM, Rahman NA, Maskell AC, Bibby, Kevin G, Blyth JP, Corcoran A, Edey J, McCracken R, Mercer, Eleanor K, Mishra, Andrew G, Nicholson. Farinaz Noorzad, Kirstie Opstad, Maria Parsonage, Andrew E Stanton, Steven Walker. British thoracic Society Guideline for pleural disease. Thorax. 2023;78: 1\u201342.","DOI":"10.1136\/thorax-2022-219784"},{"issue":"6797","key":"3396_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352.","journal-title":"Nature"},{"issue":"16","key":"3396_CR8","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233\u201341.","journal-title":"N Engl J Med"},{"issue":"7","key":"3396_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2207586","volume":"388","author":"H Ian","year":"2023","unstructured":"Ian H, Kunkler LJ, Williams, Wilma JL, Jack DA, Cameron JM, Dixon. Breast-conserving surgery with or without irradiation in early breast Cancer. J N Engl J Med. 2023;388(7):585\u201394.","journal-title":"J N Engl J Med"},{"issue":"1","key":"3396_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12957-018-1489-0","volume":"16","author":"P Majid Akrami","year":"2018","unstructured":"Majid Akrami P, Arasteh T, Eghbali HR, Shahraki S, Tahmasebi V, Zangouri A, Rezaianzadeh, Abdolrasoul Talei. Introducing novel and comprehensive models for predicting recurrence in breast cancer using the group LASSO approach: are estimates of early and late recurrence different? World J Surg Oncol. 2018;16(1):185.","journal-title":"World J Surg Oncol"},{"key":"3396_CR11","doi-asserted-by":"crossref","unstructured":"Leonard Schmiester N, Kristensen A, Frigessi. Aleix Prat, Alvaro K\u00f6hn-Luque. Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4\/6 Inhibition.Clin Cancer Res. 2024; 30(17):3779\u20133787.","DOI":"10.1158\/1078-0432.CCR-24-0244"},{"key":"3396_CR12","first-page":"101588","volume":"37","author":"TH Vo","year":"2023","unstructured":"Vo TH, Abdelaal EE-S, Jordan E. Orla O\u2019Donovan, Edel A McNeela, Jai Prakash Mehta, Sweta Rani. miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: a systematic review. Biochem Biophys Rep. 2023;37:101588.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"3396_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3779\/j.issn.1009-3419.2018.01.03","volume":"21","author":"K Xu","year":"2018","unstructured":"Xu K, Wang Y, Qi J, et al. Analysis of prognostic factors and clinical characteristics for patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion. Zhongguo Fei Ai Za Zhi. 2018;21(1):16\u201323. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2018.01.03.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"3396_CR14","doi-asserted-by":"publisher","unstructured":"Arellano-Orden E, Romero-Romero B, S\u00e1nchez-L\u00f3pez V, et al. Survivin is a negative prognostic factor in malignant pleural effusion. Eur J Clin Invest. 2018;48(4). https:\/\/doi.org\/10.1111\/eci.12895.","DOI":"10.1111\/eci.12895"},{"issue":"8","key":"3396_CR15","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, et al. Panel members. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011;22(8):1736\u201347. https:\/\/doi.org\/10.1093\/annonc\/mdr304.","journal-title":"Ann Oncol"},{"issue":"4","key":"3396_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1200\/JOP.777003","volume":"6","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Wolff AC, et al. American society of clinical oncology\/college of American pathologist\u2019s guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract. 2010;6(4):195\u20137. https:\/\/doi.org\/10.1200\/JOP.777003.","journal-title":"J Oncol Pract"},{"issue":"3","key":"3396_CR17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.chest.2021.03.059","volume":"160","author":"G Sofia Molina","year":"2021","unstructured":"Sofia Molina G, Martinez-Zayas PV, Sainz CH, Leung L, Li HB, Grosu. Roberto Adachi, David E Ost. Breast and lung effusion survival score models: improving survival prediction in patients with malignant pleural effusion and metastasis. Chest. 2021;160(3):1075\u201394.","journal-title":"Chest"},{"issue":"14","key":"3396_CR18","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.3390\/cancers15143602","volume":"15","author":"E Cansu","year":"2023","unstructured":"Cansu E, \u00d6nder, Teresa J, Ziegler R, Becker, Sara Y, Brucker AD, Hartkopf T, Engler. Andr\u00e9 Koch. Advancing Cancer therapy predictions with patient-derived Organoid models of metastatic breast Cancer. Cancers (Basel). 2023;15(14):3602.","journal-title":"Cancers (Basel)"},{"key":"3396_CR19","doi-asserted-by":"crossref","unstructured":"Karampinis I, Dionysopoulou A, Galata C, Almstedt K, Grilli M, Hasenburg A, et al. Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: a systematic literature review and pooled analysis. Thorac Cancer. 2022;13(7):883\u20138.","DOI":"10.1111\/1759-7714.14361"},{"key":"3396_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2147\/OTT.S435958","volume":"16","author":"L Chen","year":"2023","unstructured":"Chen L, Meng Z, Zhou Z, Li X, Zhao L, Jia Z, Chen J, Tian Y. Qingju Meng, Yibing Liu. Immunotherapy Combined with Chemotherapy in Relapse metaplastic breast Cancer. Onco Targets Ther. 2023;16:885\u201390.","journal-title":"Onco Targets Ther"},{"key":"3396_CR21","doi-asserted-by":"publisher","first-page":"1104246","DOI":"10.3389\/fonc.2023.1104246","volume":"13","author":"S Li","year":"2023","unstructured":"Li S, Li C, Shao W, Liu X. Luhao Sun, Zhiyong Yu. Survival analysis and prognosis of patients with breast cancer with pleural metastasis. Front Oncol. 2023;13:1104246.","journal-title":"Front Oncol"},{"issue":"5","key":"3396_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ejim.2007.09.014","volume":"19","author":"S Bielsa","year":"2008","unstructured":"Bielsa S, Salud A, Mart\u00ednez M, et al. Prognostic significance of pleural fluid data in patients with malignant effusion. Eur J Intern Med. 2008;19(5):334\u20139.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"3396_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12885-021-08219-3","volume":"21","author":"J Yamamura","year":"2021","unstructured":"Yamamura J, Kamigaki S, Fujita J, Osato H, Manabe H, Tanaka Y, et al. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients. BMC Cancer. 2021;21(1):476.","journal-title":"BMC Cancer"},{"key":"3396_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejca.2020.01.016","volume":"129","author":"E Deluche","year":"2020","unstructured":"Deluche E, Antoine A, Bachelot T, Lardy-Cleaud A, Dieras V, Brain E, et al. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008\u20132016. Eur J Cancer (Oxford Engl 1990). 2020;129:60\u201370.","journal-title":"Eur J Cancer (Oxford Engl 1990)"},{"issue":"1","key":"3396_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10549-022-06771-5","volume":"197","author":"A Laura","year":"2023","unstructured":"Laura A, Huppert Z, Walker M, Li M-O, Kim J, Callan D, Brandman M, Majure ME, Melisko, Hope S, Rugo S, Behr. A Jo Chien. Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study. Breast Cancer Res Treat. 2023;197(1):137\u201348.","journal-title":"Breast Cancer Res Treat"},{"key":"3396_CR26","doi-asserted-by":"crossref","unstructured":"Sara A, Hurvitz R, Hegg W-P, Chung S-A, Im W, Jacot V, Ganju JWY, Chiu B, Xu E, Hamilton S, Madhusudan H, Iwata S, Altintas J-W, Henning S-B, Kim V, Petry C-S, Huang W, Li J-S, Frenel. Silvia Antolin, Winnie Yeo, Giampaolo Bianchini, Sherene Loi, Junji Tsurutani, Anton Egorov, Yali Liu, Jillian Cathcart, Shahid Ashfaque, Javier Cort\u00e9s. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial. Lancet. 2023, 401(10371):105\u2013117.","DOI":"10.1016\/S0140-6736(22)02420-5"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03396-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-024-03396-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03396-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T21:01:57Z","timestamp":1728939717000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-024-03396-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3396"],"URL":"https:\/\/doi.org\/10.1186\/s12905-024-03396-2","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and has received ethical approval from the Institutional Review Board (IRB) of the Tianjin Cancer Hospital and The Affiliated General Hospital Binhai Hospital of Tianjin Medical University, approval number 20240101. Patients were consented by an informed consent process that was reviewed by the Ethics Committee of the Affiliated General Hospital Binhai Hospital of Tianjin Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"562"}}